Page last updated: 2024-08-25
ethyl protocatechuate and losartan potassium
ethyl protocatechuate has been researched along with losartan potassium in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kasiganesan, H; Sridharan, V; Wright, G | 1 |
Other Studies
1 other study(ies) available for ethyl protocatechuate and losartan potassium
| Article | Year |
|---|---|
Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
Topics: Amino Acids, Dicarboxylic; Animals; Enzyme Inhibitors; Erythropoietin; Hematocrit; Hydroxybenzoates; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Injections, Intraperitoneal; Liver; Male; Mice; Mice, Inbred Strains; Oxygen; Physical Conditioning, Animal; Physical Endurance; Procollagen-Proline Dioxygenase; Signal Transduction | 2007 |